{"id":"https://openalex.org/W4361237790","doi":"https://doi.org/10.1158/0008-5472.c.6508017.v1","title":"Data from Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models","display_name":"Data from Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361237790","doi":"https://doi.org/10.1158/0008-5472.c.6508017.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6508017.v1","doi":"https://doi.org/10.1158/0008-5472.c.6508017.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6508017.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6508017.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058391665","display_name":"Josephine Kam Tai Dermawan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josephine Kam Tai Dermawan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013023933","display_name":"Masahiro Hitomi","orcid":"https://orcid.org/0000-0002-0937-6640","observed_orcids":["https://orcid.org/0000-0002-0937-6640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masahiro Hitomi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041530623","display_name":"Daniel J. Silver","orcid":"https://orcid.org/0000-0002-7085-2626","observed_orcids":["https://orcid.org/0000-0002-7085-2626"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. Silver","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967891","display_name":"Qiulian Wu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qiulian Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058855845","display_name":"Poorva Sandlesh","orcid":"https://orcid.org/0000-0002-4775-7188","observed_orcids":["https://orcid.org/0000-0002-4775-7188"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Poorva Sandlesh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089511408","display_name":"Andrew Edward Sloan","orcid":"https://orcid.org/0000-0001-9607-5063","observed_orcids":["https://orcid.org/0000-0001-9607-5063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew E. Sloan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071922213","display_name":"Andrei A. Purmal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrei A. Purmal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015550222","display_name":"Katerina V. Gurova","orcid":"https://orcid.org/0000-0001-9189-0712","observed_orcids":["https://orcid.org/0000-0001-9189-0712"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katerina V. Gurova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021296578","display_name":"Jeremy N. Rich","orcid":"https://orcid.org/0000-0001-7845-5302","observed_orcids":["https://orcid.org/0000-0001-7845-5302"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeremy N. Rich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004589257","display_name":"Justin Durla Lathia","orcid":"https://orcid.org/0000-0003-3168-7290","observed_orcids":["https://orcid.org/0000-0003-3168-7290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justin D. Lathia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080998429","display_name":"George Robert Stark","orcid":"https://orcid.org/0000-0002-8776-9597","observed_orcids":["https://orcid.org/0000-0002-8776-9597"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George R. Stark","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5087254131","display_name":"Monica Venere","orcid":"https://orcid.org/0000-0001-6498-3390","observed_orcids":["https://orcid.org/0000-0001-6498-3390"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica Venere","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9800000190734863},{"id":"https://openalex.org/keywords/glioblastoma-stem-cells","display_name":"glioblastoma stem cells","score":0.9769999980926514},{"id":"https://openalex.org/keywords/cbl0137","display_name":"CBL0137","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.652999997138977},{"id":"https://openalex.org/keywords/asymmetric-cell-division","display_name":"asymmetric cell division","score":0.8009999990463257},{"id":"https://openalex.org/keywords/stem-cell-transcription-factors","display_name":"stem cell transcription factors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/sox2","display_name":"SOX2","score":0.843999981880188},{"id":"https://openalex.org/keywords/oct4","display_name":"Oct4","score":0.7889999747276306},{"id":"https://openalex.org/keywords/nanog","display_name":"Nanog","score":1.0},{"id":"https://openalex.org/keywords/olig2","display_name":"Olig2","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.765999972820282}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6829954981803894},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.678621768951416},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.6616989374160767},{"id":"https://openalex.org/C2777933648","wikidata":"https://www.wikidata.org/wiki/Q21114866","display_name":"SOX2","level":4,"score":0.6613880395889282},{"id":"https://openalex.org/C207701140","wikidata":"https://www.wikidata.org/wiki/Q420522","display_name":"Homeobox protein NANOG","level":5,"score":0.6409525871276855},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5756112933158875},{"id":"https://openalex.org/C170240278","wikidata":"https://www.wikidata.org/wiki/Q17928773","display_name":"FOXM1","level":4,"score":0.5560210347175598},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.5371142029762268},{"id":"https://openalex.org/C136302470","wikidata":"https://www.wikidata.org/wiki/Q7607299","display_name":"Stem cell marker","level":3,"score":0.5276281237602234},{"id":"https://openalex.org/C2779055221","wikidata":"https://www.wikidata.org/wiki/Q18035130","display_name":"OLIG2","level":5,"score":0.509847104549408},{"id":"https://openalex.org/C55427017","wikidata":"https://www.wikidata.org/wiki/Q1638475","display_name":"Cancer stem cell","level":3,"score":0.44655153155326843},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.3820491433143616},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.30158597230911255},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.26424509286880493},{"id":"https://openalex.org/C145103041","wikidata":"https://www.wikidata.org/wiki/Q1151519","display_name":"Embryonic stem cell","level":3,"score":0.19562873244285583},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.18301069736480713},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1185239851474762},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0957934558391571},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.09023129940032959},{"id":"https://openalex.org/C107459253","wikidata":"https://www.wikidata.org/wiki/Q674925","display_name":"Induced pluripotent stem cell","level":4,"score":0.09015423059463501},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.0},{"id":"https://openalex.org/C2776985911","wikidata":"https://www.wikidata.org/wiki/Q916698","display_name":"Oligodendrocyte","level":4,"score":0.0},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0},{"id":"https://openalex.org/C2778609137","wikidata":"https://www.wikidata.org/wiki/Q105790271","display_name":"Myelin","level":3,"score":0.0},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6508017.v1","doi":"https://doi.org/10.1158/0008-5472.c.6508017.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6508017.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6508017.v1","doi":"https://doi.org/10.1158/0008-5472.c.6508017.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6508017.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.4399999976158142}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3106149894","https://openalex.org/W2343526712","https://openalex.org/W2602092987","https://openalex.org/W2379279271","https://openalex.org/W2083646121","https://openalex.org/W3119363889","https://openalex.org/W2063251695","https://openalex.org/W4224217246","https://openalex.org/W4249047955","https://openalex.org/W1982580620"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"nearly":[2],"universal":[3],"recurrence":[4],"of":[5,16,60,104,120,136,147,152,171,204,216],"glioblastoma":[6],"(GBM)":[7],"is":[8],"driven":[9],"in":[10,50,90,98,126,132,178,223],"part":[11],"by":[12,206],"a":[13,33,44,187],"treatment-resistant":[14],"subpopulation":[15],"GBM":[17,62,142,179],"stem":[18,157,197],"cells":[19,68],"(GSC).":[20],"To":[21],"identify":[22],"improved":[23],"therapeutic":[24],"possibilities,":[25],"we":[26],"combined":[27],"the":[28,58,72,75,118,150,169,214],"EGFR/HER2":[29],"inhibitor":[30],"lapatinib":[31],"with":[32,65,93,182,193,210],"novel":[34],"small":[35],"molecule,":[36],"CBL0137,":[37],"which":[38],"inhibits":[39],"FACT":[40,84,86,148,167,174],"(facilitates":[41],"chromatin":[42],"transcription),":[43],"histone":[45],"chaperone":[46],"complex":[47],"predominantly":[48],"expressed":[49],"undifferentiated":[51],"cells.":[52,63],"Lapatinib":[53],"and":[54,96,116,128,164,166,190,196,208],"CBL0137":[55,81,107,137,207],"synergistically":[56],"inhibited":[57],"proliferation":[59],"patient-derived":[61],"Compared":[64],"non\u2013stem":[66],"tumor":[67,124],"(NSTC)":[69],"enriched":[70],"from":[71],"same":[73],"specimens,":[74],"GSCs":[76,91,99,105,121,205],"were":[77],"extremely":[78],"sensitive":[79],"to":[80,106,122,129,138],"monotherapy":[82],"or":[83],"knockdown.":[85],"expression":[87,151,175,200],"was":[88,176],"elevated":[89,177],"compared":[92,181],"matched":[94],"NSTCs":[95],"decreased":[97,112,117],"upon":[100],"differentiation.":[101],"Acute":[102],"exposure":[103],"increased":[108],"asymmetric":[109],"cell":[110,158,198],"division,":[111],"GSC":[113,194],"marker":[114],"expression,":[115],"capacity":[119],"form":[123],"spheres":[125],"vitro":[127],"initiate":[130],"tumors":[131,180],"vivo.":[133],"Oral":[134],"administration":[135],"mice":[139],"bearing":[140],"orthotopic":[141],"prolonged":[143],"their":[144],"survival.":[145],"Knockdown":[146],"reduced":[149],"genes":[153],"encoding":[154],"several":[155],"core":[156],"transcription":[159],"factors":[160],"(SOX2,":[161],"OCT4,":[162],"NANOG,":[163],"OLIG2),":[165],"occupied":[168],"promoters":[170],"these":[172,220],"genes.":[173],"non-neoplastic":[183],"brain":[184],"tissues,":[185],"portended":[186],"worse":[188],"prognosis,":[189],"positively":[191],"correlated":[192],"markers":[195],"gene":[199],"signatures.":[201],"Preferential":[202],"targeting":[203],"synergy":[209],"EGFR":[211],"inhibitors":[212],"support":[213],"development":[215],"clinical":[217],"trials":[218],"combining":[219],"two":[221],"agents":[222],"GBM.":[224],"Cancer":[225],"Res;":[226],"76(8);":[227],"2432\u201342.":[228],"\u00a92016":[229],"AACR.":[230]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}